Cantargia

1 follower

‌

Cantargia utvecklar en antikroppsbaserad behandling riktad mot målmolekylen IL1RAP som har potential att användas för ett flertal olika cancersjukdomar.

Industries

Biotechnology

Headquarters

Skåne län, Sweden

Employees

11-50

Links

Org chart

Göran Forsberg

CEO

Göran Forsberg

Collapse

Liselotte Larsson

COO

Dominique Tersago

Chief Medical Officer

David Liberg

VP, Research

Lars Thorsson

VP Clinical Development

Nedjad Losic

VP Biometrics

Marie Wallén Öhman

Senior Clinical Director

Ida Markholm

Senior Data Manager/Bioinformatician

Susanne Magnusson

Director Clinical Development

Patrik Renblad

CFO

Teams

Clinical Development Team

9 members

Leadership Team

5 members

Governance and Board Team

8 members

Biometrics and Research Team

4 members

Finance and Operations Team

2 members

Similar companies

NMD Pharma

4 followers

Isotopen Technologien München

1 follower

Apogee Therapeutics

1 follower

PrognomiQ

1 follower

BioLamina

1 follower

Thermo Fisher Scientific

165 followers

Gilead Sciences

128 followers

Neuralink

60 followers

Alexion Pharmaceuticals

34 followers

Lonza

31 followers

GRAIL

27 followers

Explore companies